Clinical Trials Browser

Phase 2 × OTHER × HER2-positive Refractory Advanced Cancer × Clear all

NCT02342587 2017-02-17

Safety and Clinical Activity of Lapatinib in Patients With HER2-positive Refractory Advanced Cancer

Phase 2 Completed

HER2-positive Refractory Advanced Cancer